The emerging characterization of lysine residue deacetylation on the modulation of mitochondrial function and cardiovascular biology

Circulation Research

Volumn 105, Issue 9, 2009, Pages 830-841

  Lu, Zhongping ^a   Scott, Iain ^a   Webster, Bradley R ^a   Sack, Michael N ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Apoptosis; Heart; Metabolism; Mitochondrial; Redox stress; Sirtuins; Vascular biology

Indexed keywords

ACYLTRANSFERASE; LYSINE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NONHISTONE PROTEIN; SIRTUIN; MITOCHONDRIAL PROTEIN;

ADAPTATION; BIOCHEMISTRY; CARDIOVASCULAR SYSTEM; CELL NUCLEUS; CYTOPLASM; DEACETYLATION; ENZYME ACTIVITY; HEART; HUMAN; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REDOX STRESS; REGULATORY MECHANISM; REVIEW; ACETYLATION; ANIMAL; APOPTOSIS; CARDIOVASCULAR DISEASE; ENERGY METABOLISM; HEART MITOCHONDRION; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; SIGNAL TRANSDUCTION;

ACETYLATION; ACETYLTRANSFERASES; ANIMALS; APOPTOSIS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CELL NUCLEUS; CYTOPLASM; ENERGY METABOLISM; HUMANS; LYSINE; MITOCHONDRIA; MITOCHONDRIA, HEART; MITOCHONDRIAL PROTEINS; NAD; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; SIRTUINS;

EID: 70350706093     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.204974     Document Type: Review

References (130)

1. Murgia M, Giorgi C, Pinton P, Rizzuto R Controlling metabolism, and cell death: at the heart of mitochondrial calcium, signalling. J Mol Cell Cardiol. 2009;46:781-788.
2. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev. 2008; 88: 581-609.
3. Sack MN. Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance. Cardiovasc Res. 2006;72:210-219. (Pubitemid 44515171)
4. Sack MN. Innate short-circuiting of mitochondrial, metabolism in cardiac hypertrophy: identification of novel consequences of enhanced anaplerosis. Circ Res. 2009;104:717-719.
5. Young LH, Li J, Baron SJ, Russell RR. AMP-activated protein kinase: a key stress signaling pathway in the heart. Trends Cardiovasc Med. 2005;15:110-118. (Pubitemid 41021735)
6. Narlikar GJ, Fan HY, Kingston RE. Cooperation between complexes that regulate chromatin structure and transcription. Cell. 2002; 108: 475-487.
7. Gu W, Roeder RG . Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 1997;90:595-606. (Pubitemid 27357952)
8. Spange S, Wagner T, Heinzel T, Kramer OH. Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int J Biochem Cell Biol. 2009;41:185-198.
9. Guarente L. Mitochondria-a nexus for aging, calorie restriction, and sirtuins? Cell. 2008;132:171-176. (Pubitemid 351172441)
10. Allfrey VG, Faulkner R, Mirsky AE. Acetylation and methylation of histones and their possible role in the regulation, of RNA synthesis. Proc Natl Acad Sci U S A. 1964; 51:786-794.
11. Bernd sen CE, Denu JM. Catalysis and substrate selection by histone/ protein lysine acetyltransferases. Curr Opin Struct Biol. 2008; 18: 682-689.
12. Khorasanizadeh S. The nucleosome: from genomic organization to genomic regulation. Cell, 2004;116:259-272.
13. Kim SC, Sprung R, Chen Y, Xu Y, Ball H, Pei J, Cheng T, Kho Y, Xiao H, Xiao L, Grishin NV, White M, Yang XJ, Zhao Y. Substrate and functional, diversity of lysine acetylation revealed by a proteomics survey. Mol Cell. 2006;23:607-618.
14. Zhang J, Sprung R, Pei J, Tan X, Kim S, Zhu H, Liu CF, Grishin NV, Zhao Y. Lysine acetylation is a highly abundant and evoiutionarily conserved modification in Escherichia coli. Mol Cell Proteomics. 2009; 8:215-225.
15. Marmorstein R, Roth SY. Histone acetyltransferases: function, structure, and catalysis. Curr Opin Genet Dev. 2001 ;11:155-161. (Pubitemid 32209199)
16. Yang XJ, Seto E. Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol Cell. 2008;31:449-461.
17. Kleff S, Andrulis ED, Anderson CW, Sternglanz R. Identification of a gene encoding a yeast histone H4 acetyltransferase. J Biol Chem. 1995; 270:24674-24677.
18. Brownell JE, Zhou J, Ranalli T, Kobayashi R, Edmondson DG, Roth SY, Allis CD. Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell. 1996; 84:843-851. (Pubitemid 26106854)
19. Lin Y, Fletcher CM, Zhou J, Allis CD, Wagner G. Solution structure of the catalytic domain of GCN5 histone acetyltransferase bound to coenzyme A. Nature. 1999;400:86-89. (Pubitemid 29315117)
20. McLeod CJ, Pagel L Sack MN. The mitochondrial, biogenesis regulatory program in cardiac adaptation to ischemia-a putative target for therapeutic intervention. Trends Cardiovasc Med. 2005;15:118-123.
21. Coste A, Louet JF, Lagouge M, Lerin C, Antal MC, Meziane H, Schoonjans K, Puigserver P, O'Malley BW, Auwerx J. The genetic ablation of SRC-3 protects against obesity and improves insulin sensi- tivity by reducing the acetylation of PGC-I {alpha}. Proc Natl Acad Sci U S A. 2008;105:17187-17192.
22. Kelly TJ, Lerin C, Haas W, Gygi SP, Puigserver P. GCN5-mediated transcriptional control of the metabolic coactivator PGC-lbeta through lysine acetylation. J Biol Chem. 2009;284:19945-19952.
23. Lerin. C, Rodgers JT, Kalume DE, Kim. SH, Pandey A, Puigserver P. GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha. Cell Metab. 2006;3:429-438. (Pubitemid 43811779)
24. Neal KC, Pannuti A, Smith ER, Lucchesi JC. A new human member of the MYST family of histone acetyl transferases with high sequence similarity to Drosophila MOF. Biochim Biophys Acta. 2000; 1490: 170-174. (Pubitemid 30070149)
25. Avvakumov N, Cote J. The MYST family of histone acetyltransferases and their intimate links to cancer. Oncogene. 2007;26:5395-5407.
26. Kim. MS, Merlo X, Wilson C, Lough J. Co-activation of atrial natriuretic factor promoter by Tip60 and serum response factor. J Biol Chem. 2006;281:15082-15089.
27. Eckner R. p300 and CBP as transcriptional regulators and targets of oncogenic events. Biol Chem. 1996;377:685-688.
28. McKenna NJ, Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW. Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol. 1999;69:3-12. (Pubitemid 29305520)
29. Nemoto S, Fergusson MM, Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-I{alpha}. J Biol Chem. 2005;280:16456-16460.
30. Shikama N, Lutz W, Kretzschmar R, Sauter N, Roth JF, Marino S, Wittwer J, Scheidweiler A, Eckner R. Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation. EMBO J. 2003;22:5175-5185.
31. Kawamura T, Ono K, Morimoto T, Wada H, Hirai M, Hidaka K, Morisaki T, Heike T, Nakahata T, Kita T, Hasegawa K. Acetylation of GATA-4 is involved in the differentiation of embryonic stem cells into cardiac myocytes. J Biol Chem. 2005; 280:19682-19688. (Pubitemid 41379492)
32. Takaya T, Kawamura T, Morimoto T, Ono K, Kita T, Shimatsu A, Hasegawa K. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes. J Biol Chem. 2008; 283:9828-9835.
33. Yang XJ, Seto E. The Rpd3/Hdal family of lysine deacetylases: from bacteria and yeast to mice and men. Nat Rev Mol Cell Biol. 2008; 9: 206-218. (Pubitemid 351301825)
34. Blander G, Guarente L. The Sir2 family of protein deacetylases. Annu Rev Biochem. 2004;73:417-435.
35. Schwer B, Verdin E. Conserved metabolic regulatory functions of sirtuins. Cell Metab. 2008;7:104-112. (Pubitemid 351168554)
36. Frye RA. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun. 2000;273:793-798. (Pubitemid 30599063)
37. Haigis MC, Mostoslavsky R, Haigis KM, Fahie K, Christodoulou DC, Murphy AJ, Valenzuela DM, Yancopoulos GD, Karow M, Blander G, Wolberger C, Prolia TA, Weindruch R, Alt FW, Guarente L. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell. 2006;126:941-954.
38. Nakagawa T, Lomb DJ, Haigis MC, Guarente L. SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell. 2009;137:560-570.
39. Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science. 2000;289:2126-2128. (Pubitemid 30736519)
40. Anderson. RM, Bitterman KJ, Wood JG, Medvedik O, Cohen H, Lin SS, Manchester JK, Gordon JI, Sinclair DA. Manipulation of a nuclear NAD+ salvage pathway delays aging without altering steady-state NAD+ levels. J Biol Chem. 2002;277:18881-18890.
41. Dioum EM, Chen R, Alexander MS, Zhang Q, Hogg RT, Gerard RD, Garcia JA. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin. 1. Science. 2009;324: 1289-1293.
42. Bitterman KJ, Anderson RM, Cohen HY, Latorre-Esteves M, Sinclair DA. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRTl. J Biol Chem. 2002;277:45099-45107.
43. Revollo JR, Grimm AA, Imai S. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol. 2007;23:164-170. (Pubitemid 46192971)
44. Ito Y, Yonekura R, Maruta K, Koike T, Nakagami Y, Shibata K, Saito K, Nagamura Y. Tryptophan metabolism was accelerated by exercise in rat. Adv Exp Med Biol. 2003;527:531-535. (Pubitemid 38197682)
45. Shin M., Ohnishi. M, Sano K, Umezawa C. NAD levels in the rat primary cultured hepatocytes affected by peroxisome-proliferators. Adv Exp Med Biol. 2003;527:653-658.
46. Revollo JR, Grimm AA, Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem. 2004;279:50754-50763.
47. Berger F, Lau C, Dahlmann M, Ziegler M. Subcellular compartmentation and differential, catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J Biol Chem. 2005; 280:36334-36341.
48. Yang H, Yang T, Baur JA, Perez E, Matsui T, Carmona JJ, Lamming DW, Souza-Pinto NC, Bohr VA, Rosenzweig A, de CR, Sauve AA, Sinclair DA. Nutrient-sensitive mitochondrial NAD+ levels dictate cell, survival. Cell. 2007;130:1095-1107.
49. Landry J, Sutton A, Tafrov ST, Heller RC, Stebbins J, Pillus L, Sternglanz R. The silencing protein SIR2 and its homologs are NADdependent protein deacetylases. Proc Natl Acad Sci USA. 2000;97: 5807-5811. (Pubitemid 30367480)
50. Tanner KG, Landry J, Sternglanz R, Denu JM. Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc Natl Acad Sci U S A. 2000;97:14178-14182. (Pubitemid 32016550)
51. Rohas LM, St-Pierre J, Uldry M, Jager S, Handschin C, Spiegelman BM. A fundamental system of cellular energy homeostasis regulated by PGC-lalpha. Proc Natl Acad Sci U S A. 2007 May 8;104:7933-7938. (Pubitemid 47185854)
52. Kouzarides T. Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 2000; 19:1176-11.79.
53. Di OM, Dani N, Stilla A, Corda D. Physiological relevance of the endogenous mono(ADP-ribosyl)ation of cellular proteins. FEBS J. 2005;272: 4565-4575.
54. Corda D, Di GM. Functional aspects of protein mono-ADP-ribosylation. EMBO J. 2003;22:1953-1958.
55. Liszt G, Ford E, Kurtev M, Guarente L. Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J Biol Chem. 2005;280:21313-21320. (Pubitemid 40805693)
56. Du J, Jiang H, Lin H. Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogs and 32-P-NAD. Biochemistry. 2009;48: 2878-2890.
57. Dani N, Stilla A, Marchegiani A, Tamburro A, Till S, Ladurner AG, Corda D, Di GM. Combining affinity purification, by ADP-ribosebinding macro domains with mass spectrometry to define the mammalian ADP-ribosyl proteome. Proc Natl Acad Sci U S A. 2009;106: 4243-4248.
58. Schlicker C, Gertz M, Papatheodorou P, Kachholz B, Becker CF, Steegborn C. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol. 2008;382:790-801.
59. Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y. Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem. 2007;282:6823-6832. (Pubitemid 47100909)
60. Schwer B, North BJ, Frye RA, Ott M, Verdin E. The human, silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J Cell Biol. 2002;158:647-657. (Pubitemid 34920104)
61. Onyango P, Celic I, McCaffery JM, Boeke JD, Feinberg AP. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc Natl Acad Sci U S A. 2002;99:13653-13658.
62. Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, Kim J, Yancopoulos G, Valenzuela D, Murphy A, Yang Y, Chen Y, Hirschey MD, Branson RT, Haigis M, Guarente LP, Farese RV Jr, Weissman S, Verdin E, Schwer B. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol. 2007; 27:8807-8814.
63. Cooper HM, Spelbrink JN. The human SIRT3 protein deacetylase is exclusively mitochondrial. Biochem J. 2008;41.1:279-285.
64. Sundaresan NR, Samant SA, Pillai VB, Rajamohan SB, Gupta MP. SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Mol Cell Biol. 2008;28:6384-6401.
65. Nakamura Y, Ogura M, Tanaka D, Inagaki N. Localization of mouse mitochondrial. SIRT proteins: shift of SIRT3 to nucleus by co-expression with SIRT5. Biochem Biophys Res Commun. 2008;366:174-179. (Pubitemid 50010675)
66. Scher MB, Vaquero A, Reinberg D. SirT3 is a nuclear NAD+dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes Dev. 2007;21:920-928. (Pubitemid 46625641)
67. Shi T, Wang F, Stieren E, Tong Q. SIRT3, a mitochondrial, sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem. 2005;280:13560-13567.
68. Cohen HY, Miller C, Bitterman KJ, Wall. NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de CR, Sinclair DA. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 2004;305:390-392. (Pubitemid 38938153)
69. Wang F, Nguyen M, Qin FX, Tong Q. SIRT2 deacetylates FOX03a in response to oxidative stress and caloric restriction. Aging Cell. 2007;6: 505-514.
70. Chen D, Bruno J, Easlon. E, Lin SJ, Cheng HL, Alt FW, Guarente L. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. 2008;22:1753-1757. (Pubitemid 351915500)
71. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control, of glucose homeostasis through a complex of PGC1alpha and SIRT1. Nature. 2005;434:113-118.
72. Pagel-Langenickel. I, Bao J, Joseph JJ, Schwartz DR, Mantell BS, Xu X, Raghavachari N, Sack MN. PGC-1alpha integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle. J Biol Chem. 2008;283:22464-22472.
73. Yechoor VK, Patti ME, Ueki K, Laustsen PG, Saccone R, Rauniyar R, Kahn CR. Distinct pathways of insulin-regulated versus diabetesregulated gene expression: an in vivo analysis in MIRKO mice. Proc Natl Acad Sci U S A. 2004;101:16525-16530.
74. Lanza IR, Short DK, Short KR, Raghavakaimal S, Basu R, Joyner MJ, McConnell JP, Nair KS. Endurance exercise as a countermeasure for aging. Diabetes. 2008;57:2933-2942.
75. Alcendor RR, Gao S, Zhai P, Zablocki D, Holle E, Yu X, Tian B, Wagner T, Vatner SF, Sadoshima J. Sirt 1. regulates aging and resistance to oxidative stress in the heart Circ Res. 2007;100:1512-1521.
76. Lynn EG, McLeod CJ, Gordon JP, Bao J, Sack MN. SIRT2 is a negative regulator of anoxia-reoxygenation tolerance via regulation of 14-3-3 zeta and BAD in H9c2 cells. FEBS Lett. 2008;582:2857-2862.
77. Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, Auwerx. J. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1. activity. Nature. 2009; 458:1.056-1.060.
78. Lan F, Cacicedo JM, Ruderman N, Ido Y. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem. 2008;283: 27628-27635.
79. Finck BN, Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1.) regulatory cascade in cardiac physiology and disease. Circulation. 2007; 115:2540-2548.
80. Lin J, Tarr PT, Yang R, Rhee J, Puigserver P, Newgard CB, Spiegelman BM. PGC-1beta in the regulation of hepatic glucose and energy metabolism. J Biol Chem. 2003;278:30843-30848.
81. Brunet A, Sweeney LB, Sturgill. JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 2004;303: 2011.-2015.
82. van der HA, Tertoolen LG, de Vries-Smits LM, Frye RA, Medema RH, Burgering BM. FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). J Biol Chem. 2004;279: 28873-28879.
83. Dinardo MM, Musicco C, Fracasso F, Milella F, Gadaleta MN, Gadaleta G, Cantatore P. Acetylation and level of mitochondrial, transcription factor A in several organs of young and old rats. Biochem Biophys Res Commun. 2003;301:187-191.
84. Bremer J. Carnitine in intermediary metabolism. Reversible acetylation of carnitine by mitochondria. J Biol Chem. 1962;237:2228-2231.
85. Zammit VA. Carnitine acyltransferases: functional significance of subcellular distribution and membrane topology. Prog Lipid Res. 1999;38: 199-224.
86. Law IK, Liu L, Xu A, Lam. KS, Vanhoutte PM, Che CM, Leung PT, Wang Y. Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti-aging and metabolic effects of sirtuins. Proteomics. 2009;9:2444-2456.
87. Hallows WC, Lee S, Denn JM. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci U S A. 2006;103: 10230-10235.
88. Schwer B, Bunkenborg J, Verdin RO, Andersen JS, Verdin. E. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc Natl Acad Sci USA. 2006;103: 10224-10229.
89. Fujino T, Kondo J, Ishikawa M, Morikawa K, Yamamoto TT. Acetyl-CoA. synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate. J Biol Chem. 2001;276:11420-11426. (Pubitemid 38089336)
90. Ahn BH, Kim HS, Song S, Lee IH, Liu J, Vassilopoulos A, Deng CX, Finkel T. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci U S A. 2008;105:14447-14452.
91. Distler AM, Kerner J, Lee K, Hoppel. CL. Post-translational modifications of mitochondrial, outer membrane proteins. Methods Enzymol. 2009;457:97-115.
92. Alcendor RR, Kirshenbaum LA, Imai S, Vatner SF, Sadoshima J. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ Res. 2004;95:971-980.
93. McLeod CJ, Jeyabalan AP, Minners JO, Clevenger R, Hoyt RF Jr, Sack MN. Delayed ischemic preconditioning activates nuclear-encoded electron-transfer- chain gene expression in parallel, with enhanced postanoxic mitochondrial respiratory recovery. Circulation. 2004;110: 534-539. (Pubitemid 39031169)
94. Sawada M, Sun W, Hayes P, Leskov K, Boothman DA, Matsuyama S. Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat Cell Biol, 2003;5:320-329. (Pubitemid 36432296)
95. Cohen HY, Lavu S, Bitterman. KJ, Hekking B, Imahiyerobo TA, Miller C, Frye R, Ploegh H, Kessler BM, Sinclair DA. Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol Cell. 2004;13:627-638. (Pubitemid 38368121)
96. Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, Gupta MP. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest. 2009;119:2758-2771.
97. Vakhrusheva O, Smolka C, Gajawada P, Kostin S, Boettger T, Kubin T, Braun T, Bober E. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res. 2008;102:703-710.
98. Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease: from, marvel to menace. Circulation. 2006;113:1708-1714. (Pubitemid 43754233)
99. Brown GC, Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal, respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 1994;356:295-298.
100. Nisoli E, Falcone S, Tonello C, Cozzi V, Palomba L, Fiorani M, Pisconti A, Brunelli S Cardile A, Francolini M, Cantoni O, Carruba MO, Moneada S, Clementi E. Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci USA. 2004;101:16507-16512.
101. Shiva S, Sack MN, Greer JJ, Duranski M, Ringwood LA, Burwell L, Wang X, MacArthur PH, Shoja A, Raghavachari N, Calvert JW, Brookes PS, Lefer DJ, Gladwin MT. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med. 2007;204:2089-2102.
102. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, Bracale R, Valerio A, Francolini M, Moneada S, Carruba MO. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science. 2003;299:896-899. (Pubitemid 36182449)
103. Mattagajasingh I, Kim CS, Naqvi A, Yamamori T, Hoffman TA, Jung SB, DeRicco J, Kasuno K, Irani K. SIRT1 promotes endotheliumdependent vascular relaxation by activating endothelial, nitric oxide synthase. Proc Natl Acad Sci USA. 2007;104:14855-14860.
104. Sasaki S, Higashi Y, Nakagawa K, Kimura M, Noma K, Sasaki S, Hara K, Matsuura H, Goto C, Oshima T, Chayama K. A low-calorie diet improves endothellum-dependent vasodilation in obese patients with essential hypertension. Am J Hypertens. 2002;15:302-309.
105. Benigni A, Coma D, Zoja C, Sonzogni. A, Latini R, Salio M, Conti S, Rottoli D, Longaretti L, Cassis P, Morigi M, Coffman TM, Remuzzi G. Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest. 2009;119:524-530.
106. Gembardt F, Heringer-Walther S, van Esch JH, Sterner-Kock A, van. VR, Le TH, Garrelds IM, Coffman. TM, Danser AH, Schultheiss HP, Walther T. Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors. FASEB J. 2008;22:3068-3077.
107. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A. 2006;103:17985-17990.
108. Miyazaki R, Ichiki T, Hashimoto T, Inanaga K, Imayama I, Sadoshima J, Sunagawa K. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler Thromb Vase Biol, 2008;28:1263-1269.
109. Loor G, Schumacker PT. Role of hypoxia-inducible factor in cell, survival during myocardial ischemia-reperfusion. Cell Death Differ. 2008;15:686-690.
110. Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB, Lopaschuk GD, Muoio DM. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal, muscle insulin resistance. Cell Metab. 2008;7:45-56.
111. Pound KM, Sorokina N, Ballal K, Berkich DA, Fasano M, Lanoue KF, Taegtmeyer H, O'Donnell JM, Lewandowski ED. Substrate-enzyme competition attenuates upregulated anaplerotic flux through malic enzyme in hypertrophied rat heart and restores triacylglyceride content: attenuating upregulated anaplerosis in hypertrophy. Circ Res. 2009; 104: 805-81.2.
112. Opie LH, Sack MN. Metabolic plasticity and the promotion of cardiac protection in ischemia and ischemic preconditioning. J Mol Cell Cardiol. 2002;34:1077-1089.
113. Ussher JR, Lopaschuk GD. The malonyl CoA axis as a potential, target for treating ischaemic heart disease. Cardiovasc Res. 2008;79:259-268.
114. Sack MN, Kelly DP. The energy substrate switch during development of heart failure: gene regulatory mechanisms. Int J Mol Med, 1998; I : 17-24.
115. Sharma N, Okere IC, Duda MK, Chess DJ, O'Shea KM, Stanley WC. Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy. Cardiovasc Res. 2007;73:257-268. (Pubitemid 44937701)
116. Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, Abel ED. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation. 2005; 112:2686-2695.
117. Sack MN. Type 2 diabetes, mitochondrial biology and the heart. J Mol Cell Cardiol. 2009;46:842-849.
118. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. ATP-citrate lyase links cellular metabolism to histone acetylation. Science. 2009;324:1076-1080.
119. Rathmell JC, Newgard CB. Biochemistry. A glucose-to-gene link. Science. 2009;324:1021-1022.
120. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le CD, Shaw RJ, Navas P, Puigserver P, Ingram. DK, de CR, Sinclair DA. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444:337-342. (Pubitemid 44764104)
121. Dasgupta B, Milbrandt J. Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci U S A. 2007;104:7217-7222.
122. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC1 alpha. Cell. 2006;127:1109-1122. (Pubitemid 44894520)
123. Goh SS, Woodman OL, Pepe S, Cao AH, Qin C, Ritchie RH. The red wine antioxidant resveratrol prevents cardiomyocyte injury following ischemia-reperfusion via multiple sites and mechanisms. Antioxid Redox Signal. 2007;9:101-113. (Pubitemid 44901876)
124. Feige JN, Lagouge M, Canto C, Strehle A, Houten SM, Milne JC, Lambert PD, Mataki C, Elliott PJ, Auwerx J. Specific SIRT1. activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab. 2008;8:347-358.
125. Gutierrez M, Andrianasolo EH, Shin WK, Goeger DE, Yokochi A, Schemies J, Jung M, France D, Cornell-Kennon S, Lee E, Gerwick WH. Structural and synthetic investigations of tanikolide dimer, a SIRT2 selective inhibitor, and tanikolide seco-acid from the Madagascar marine cyanobacterium Lyngbya majuscula. J Org Chem. 2009;74:5267-5275.
126. Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, Amore AM, Volk CB, Maxwell MM, Rochet JC, McLean PJ, Young AB, Abagyan R, Feany MB, Hyman BT, Kazantsev AG. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science. 2007;317:516-519.
127. Zhang Y, Au. Q, Zhang M, Barber JR, Ng SC, Zhang B. Identification of a small molecule SIRT2 inhibitor with selective tumor cytotoxicity. Biochem Biophys Res Commun. 2009;386:729-733.
128. Feige JN, Auwerx J. Transcriptional targets of sirtuins in the coordination of mammalian physiology. Curr Opin Cell Biol, 2008;20: 303-309.
129. Lee IH, Cao L, Mostoslavsky R, Lombard DB, Liu J, Bruns NE, Tsokos M, Alt FW, Finkel T. A role for the NAD-dependent deacetylase Sirtl in the regulation of autophagy. Proc Natl Acad Sci USA. 2008;105: 3374-3379. (Pubitemid 351723560)
130. Nakahata Y, Kaluzova M, Grimaldi B, Sahar S, Hirayama J, Chen D, Guarente LP, Sassone-Corsi. P. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell. 2008;134:329-340. (Pubitemid 352010336)